Spruce Biosciences, Inc. (SPRB)
NASDAQ·Healthcare·Biotechnology
$41.40
-0.48%
Mkt Cap $36.05M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$191.00
Range $140.00 – $283.00
Implied Upside
+361.4%
Consensus $191.00 vs current $41.40
NASDAQ·Healthcare·Biotechnology
$41.40
-0.48%
Mkt Cap $36.05M
No recent rating data.
Price Target (6 analysts)
$191.00
Range $140.00 – $283.00
+361.4%
Consensus $191.00 vs current $41.40